Applied

Type

Addition

Confidence

95%

Created

Mar 19, 2026

Evidence

2 sources

Rationale

The original section was extremely brief. Integrating the 2024 PAD guidelines and the 2022 Aortic Disease guidelines provides necessary clinical context, including Class 1 recommendations, the role of non-contrast MRA in renal failure, and the advantage of MRA in reducing radiation exposure for surveillance. All abbreviations were expanded on first use as per instructions.

Content Changes

* AlternativeMagnetic resonance angiography (MRA) is a Class 1 recommendation for the anatomic assessment of lower extremity peripheral artery disease (PAD) when revascularization is planned [@svs2024].
* It serves as an alternative when computed tomography angiography (CTA) is contraindicated (renaldue dysfunction,to renal dysfunction or iodinated contrast allergy).allergy [@svs2024].
* CE-magneticContrast-enhanced magnetic resonance angiography (MRA)(CE-MRA) provides high-resolution images.images for both PAD and aortic disease, including aneurysms and dissections [@aha2022, @svs2024].
* MRA is particularly useful for serial surveillance of aortic disease to minimize ionizing radiation exposure [@aha2022].
* For patients with severe chronic kidney disease (CKD), non-contrast MRA techniques may be utilized to avoid the risk of nephrogenic systemic fibrosis (NSF) associated with certain gadolinium-based contrast agents [@svs2024].